期刊文献+

PPARγ及VEGF在胃癌组织中的表达及临床相关性

The Expression and Clinical Significance of PPARγ and VEGF in Gastric Cancer Tissues
下载PDF
导出
摘要 目的:研究过氧化酶增殖因子活化受体和血管内皮生长因子在胃癌组织中的表达及其相关性。方法:采用免疫组化法检测40例胃癌手术中的PPARγ、VEGF表达,同时选取相同病例的癌旁组织、癌旁正常组织作为对照。结果:免疫组化提示PPARγ阳性率在胃癌中是72.5%,癌旁组织中是25%,癌旁正常组织中是17.5%,三者表达差异有统计学意义;VEGF阳性率在胃癌中是75%,癌旁组织中是40%,癌旁正常组织中是10%,三者表达差异有统计学意义;PPARγ的蛋白表达与VEGF表达有关(r=0.388,P=0.013);结论:PPARγ可能影响胃癌新生血管的形成。 Objective:To study the significance of expression of peroxisome proliferator-activated receptor gamma(PPARγ)and vascular endothelial growth factor(VEGF)in gastric carcinoma as well as their correlation.Methods:The tissue chips of 40 cases of gastric cancer tissues were adopted by the immunohistochemical methods compared with paired adjacent mucosa and normal mucosa for 40 same cases.Results:The positive rate of PPARγ protein was significantly higher in gastric carcinoma of 40 cases(72.5%)than in their paired adjacent mucosa of 40 cases(25%)and normal mucosa of 40 cases(17.5%),PPARγ espression was well correlated with VEGF(r=0.388,P=0.013)in protein level.Conclusion:The results suggestcd that there was a closely relationship between PPARγ and VEGF and PPARγ might be the effective angiogenesis for gastric cancer.
出处 《华西医学》 CAS 2008年第2期231-233,共3页 West China Medical Journal
基金 国家自然科学基金资助项目(NO.30370639)
关键词 胃癌 氧化酶增殖因子活化受体 血管内皮生长因子 免疫组织化学 Gastric carcinoma peroxisome proliferator-activated receptor gamma Vascular endothelial growth factor Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献56

  • 1Herschman HR. Prostaglandin synthase 2. Biochem Bioph Acta 1996; 1299:125-140.
  • 2Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Natl Cancer Inst 1998; 90:1609-1620.
  • 3Eberhart CE, Coffery RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107:1183-1188.
  • 4Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S, Talbot IC. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 1999;187:295-301.
  • 5Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cylooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58:2929-2934.
  • 6Ristimaki A, Honkanen N, Jankala H. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-1280.
  • 7Wolff H, Ssukkonen K, Anttila S, Karjalainen A, Vainio H,Restimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998; 58:4997-5001.
  • 8Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KN,Masferrer JL, Woerner BM, Snyder PW, Koki AT. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 1999; 59: 5647-5650.
  • 9Tsujii M, DuBois RN. Alterations in celluar adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83:493-501.
  • 10DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996; 56:733-737.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部